Colorectal Cancer Screening In American Indian & Alaska Native Communities – November 28, 2017

Colorectal Cancer Screening In American Indian & Alaska Native Communities – November 28, 2017
This webinar explored the opportunities and barriers related to delivering quality colorectal cancer screening and follow-up care in health care settings serving American Indian and Alaska Native (AI/AN) communities. The webinar provided a review of basic basic data on colorectal cancer incidence, mortality, and screening rates in AI/AN populations, an overview of the American Cancer Society and the NCCRT’s work to address this issue, and presentations from two AI/AN-serving healthcare systems about their innovative approaches to increasing colorectal cancer screening.
Learn more about the American Cancer Society and the NCCRT’s work to address this issue in the post-meeting report from the April 2016 one-day summit to explore the challenges and potential solutions to improving access to quality colorectal cancer screening in this population.
Speakers:
- Kris Rhodes, MPH, Chief Executive Officer, American Indian Cancer Foundation (Moderator)
- Laura Makaroff, DO, Senior Director, Cancer Control Intervention, American Cancer Society, Inc.
- Jessica Deaton, RN, BSN, Care Manager, Oklahoma City Indian Clinic
- Richard Mousseau, MS, Director, Community Health Prevention Programs, Great Plains Tribal Chairmen’s Health Board
Explore More

Increasing Colorectal Cancer Screening in Rural Communities: A Practical Guide
This guidebook is designed to support key community partners in understanding and overcoming the unique challenges and common barriers to CRC screening faced in rural communities.

ACS Colorectal Cancer Mortality Disparities Learning Community
This five session learning community was created to address CRC mortality disparities within state cancer coalition work and took place from May-September 2025.

Clinician’s Reference: Stool-Based Tests for Colorectal Cancer Screening
This revised resource is designed to introduce (or reintroduce) clinicians to the value of stool-based testing for colorectal cancer.